THOMAS MONATH to Animals
This is a "connection" page, showing publications THOMAS MONATH has written about Animals.
Connection Strength
1.532
-
rVSV?G-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model. Viruses. 2025 Feb 28; 17(3).
Score: 0.054
-
Japanese Encephalitis: Risk of Emergence in the United States and the Resulting Impact. Viruses. 2023 12 28; 16(1).
Score: 0.050
-
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease. Front Immunol. 2023; 14:1216225.
Score: 0.049
-
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential. PLoS Pathog. 2022 06; 18(6):e1010658.
Score: 0.045
-
A short history of Lassa fever: the first 10-15 years after discovery. Curr Opin Virol. 2019 08; 37:77-83.
Score: 0.037
-
Responding to the threat of urban yellow fever outbreaks. Lancet Infect Dis. 2017 03; 17(3):248-250.
Score: 0.031
-
Yellow Fever Remains a Potential Threat to Public Health. Vector Borne Zoonotic Dis. 2016 08; 16(8):566-7.
Score: 0.030
-
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus. Viruses. 2013 Dec 09; 5(12):3048-70.
Score: 0.025
-
Vaccines against diseases transmitted from animals to humans: a one health paradigm. Vaccine. 2013 Nov 04; 31(46):5321-38.
Score: 0.024
-
Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes. Virus Res. 2013 Sep; 176(1-2):280-4.
Score: 0.024
-
Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model. Vaccine. 2011 Aug 11; 29(35):6008-16.
Score: 0.021
-
An inactivated cell-culture vaccine against yellow fever. N Engl J Med. 2011 Apr 07; 364(14):1326-33.
Score: 0.021
-
Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity. Vaccine. 2010 May 14; 28(22):3827-40.
Score: 0.019
-
Introduction: one health perspective. ILAR J. 2010; 51(3):193-8.
Score: 0.019
-
Yellow fever recommendations for tourists to Kenya: a flawed risk assessment. J Travel Med. 2009 Mar-Apr; 16(2):146; author reply 146-7.
Score: 0.018
-
Use of a surrogate chimeric virus to detect West Nile virus-neutralizing antibodies in avian and equine sera. Clin Vaccine Immunol. 2009 Jan; 16(1):134-5.
Score: 0.017
-
Improving vaccine coverage in Africa. Lancet. 2008 Feb 02; 371(9610):386.
Score: 0.017
-
Dengue and yellow fever--challenges for the development and use of vaccines. N Engl J Med. 2007 Nov 29; 357(22):2222-5.
Score: 0.016
-
Treatment of yellow fever. Antiviral Res. 2008 Apr; 78(1):116-24.
Score: 0.016
-
Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. Vaccine. 2008 Jan 24; 26(4):581-8.
Score: 0.016
-
Analysis of ChimeriVax Japanese Encephalitis Virus envelope for T-cell epitopes and comparison to circulating strain sequences. Vaccine. 2007 Nov 19; 25(47):8077-84.
Score: 0.016
-
Experimental infection of Culex annulirostris, Culex gelidus, and Aedes vigilax with a yellow fever/Japanese encephalitis virus vaccine chimera (ChimeriVax-JE). Am J Trop Med Hyg. 2006 Oct; 75(4):659-63.
Score: 0.015
-
A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A. 2006 Apr 25; 103(17):6694-9.
Score: 0.015
-
Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys. Biologicals. 2005 Sep; 33(3):131-44.
Score: 0.014
-
Yellow fever vaccine. Expert Rev Vaccines. 2005 Aug; 4(4):553-74.
Score: 0.014
-
Interview with Thomas P. Monath, M.D. Interview by Vicki Glaser. Vector Borne Zoonotic Dis. 2005; 5(3):300-4.
Score: 0.013
-
ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy. J Virol. 2004 Nov; 78(22):12497-507.
Score: 0.013
-
Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool. Am J Trop Med Hyg. 2004 Nov; 71(5):639-45.
Score: 0.013
-
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense. Int J Infect Dis. 2004 Oct; 8 Suppl 2:S31-44.
Score: 0.013
-
A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys. J Virol. 2004 Sep; 78(18):9998-10008.
Score: 0.013
-
Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J Virol. 2004 May; 78(9):4761-75.
Score: 0.013
-
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis. 2003 Oct 15; 188(8):1213-30.
Score: 0.012
-
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med. 2003 Sep; 9(9):1125-30.
Score: 0.012
-
Preface to the flaviviruses. Adv Virus Res. 2003; 60:ix-xi.
Score: 0.012
-
Preface to volume 60 the flaviviruses: pathogenesis and immunity. Adv Virus Res. 2003; 60:xiii-xiv.
Score: 0.012
-
Pathogenesis and pathophysiology of yellow fever. Adv Virus Res. 2003; 60:343-95.
Score: 0.012
-
Epidemiology and ecology of yellow fever virus. Adv Virus Res. 2003; 61:291-315.
Score: 0.012
-
Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis. Adv Virus Res. 2003; 61:469-509.
Score: 0.012
-
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2. Emerg Microbes Infect. 2022 Dec; 11(1):2724-2734.
Score: 0.012
-
Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model. Emerg Infect Dis. 2002 Dec; 8(12):1392-7.
Score: 0.012
-
Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease. Am J Trop Med Hyg. 2022 11 14; 107(5):1091-1098.
Score: 0.011
-
Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Virology. 2002 Jun 20; 298(1):146-59.
Score: 0.011
-
Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J Virol. 2002 Feb; 76(4):1932-43.
Score: 0.011
-
Japanese encephalitis vaccines: current vaccines and future prospects. Curr Top Microbiol Immunol. 2002; 267:105-38.
Score: 0.011
-
Prospects for development of a vaccine against the West Nile virus. Ann N Y Acad Sci. 2001 Dec; 951:1-12.
Score: 0.011
-
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission. Emerg Microbes Infect. 2021 Dec; 10(1):651-663.
Score: 0.011
-
Sterilizing immunity against experimental Helicobacter pylori infection is challenge-strain dependent. Vaccine. 2001 Sep 14; 19(32):4883-95.
Score: 0.011
-
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol. 2001 Aug; 75(16):7290-304.
Score: 0.011
-
Yellow fever vector live-virus vaccines: West Nile virus vaccine development. Trends Mol Med. 2001 Aug; 7(8):350-4.
Score: 0.011
-
Yellow fever: an update. Lancet Infect Dis. 2001 Aug; 1(1):11-20.
Score: 0.011
-
West Nile virus vaccine. Curr Drug Targets Infect Disord. 2001 May; 1(1):37-50.
Score: 0.010
-
The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines. Vaccine. 2020 11 17; 38(49):7708-7715.
Score: 0.010
-
The Origin of COVID-19 and Why It Matters. Am J Trop Med Hyg. 2020 Sep; 103(3):955-959.
Score: 0.010
-
Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol. 2000 Jun; 74(12):5477-85.
Score: 0.010
-
Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection. Infect Immun. 2000 May; 68(5):2775-82.
Score: 0.010
-
Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol. 2000 Feb; 74(4):1742-51.
Score: 0.009
-
Comparative evaluation of pathogenicity of three isolates of vesicular stomatitis virus (Indiana serotype) in pigs. J Gen Virol. 2019 11; 100(11):1478-1490.
Score: 0.009
-
Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases. Vaccine. 2019 10 08; 37(43):6248-6254.
Score: 0.009
-
Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine. 1999 Aug 06; 17(23-24):3072-82.
Score: 0.009
-
Intranasal antibody prophylaxis for protection against viral disease. Clin Microbiol Rev. 1999 Jul; 12(3):383-93.
Score: 0.009
-
Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology. 1999 May 10; 257(2):363-72.
Score: 0.009
-
Facing up to re-emergence of urban yellow fever. Lancet. 1999 May 08; 353(9164):1541.
Score: 0.009
-
Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine. 1999 Apr 09; 17(15-16):1869-82.
Score: 0.009
-
Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection. Vaccine. 1999 Mar 17; 17(11-12):1394-403.
Score: 0.009
-
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine. 1999 Mar 17; 17(11-12):1493-505.
Score: 0.009
-
Ecology of Marburg and Ebola viruses: speculations and directions for future research. J Infect Dis. 1999 Feb; 179 Suppl 1:S127-38.
Score: 0.009
-
Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med. 1998 Dec 21; 188(12):2277-88.
Score: 0.009
-
Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun. 1998 Sep; 66(9):4340-6.
Score: 0.009
-
Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun. 1998 Jun; 66(6):2879-86.
Score: 0.008
-
Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species. Hum Vaccin Immunother. 2018 04 03; 14(4):994-1002.
Score: 0.008
-
Vaccine development against infection with Helicobacter pylori. Br Med Bull. 1998; 54(1):229-41.
Score: 0.008
-
Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia. N Engl J Med. 2017 10 12; 377(15):1438-1447.
Score: 0.008
-
Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins. Infect Immun. 1997 Oct; 65(10):4288-98.
Score: 0.008
-
Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology. 1997 Oct; 113(4):1118-28.
Score: 0.008
-
Proposed revision to the taxonomy of the genus Pestivirus, family Flaviviridae. J Gen Virol. 2017 Aug; 98(8):2106-2112.
Score: 0.008
-
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. CMAJ. 2017 Jun 19; 189(24):E819-E827.
Score: 0.008
-
Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector. Clin Vaccine Immunol. 2017 Jan; 24(1).
Score: 0.008
-
Epidemic arboviral diseases: priorities for research and public health. Lancet Infect Dis. 2017 03; 17(3):e101-e106.
Score: 0.008
-
Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens. Vaccine. 2017 01 03; 35(1):1-9.
Score: 0.008
-
Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family. J Gen Virol. 2016 Nov; 97(11):2894-2907.
Score: 0.008
-
Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. J Infect Dis. 1996 Aug; 174(2):256-61.
Score: 0.007
-
Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Vaccine. 2016 12 12; 34(51):6610-6616.
Score: 0.007
-
Antigenicity of amino-acid sequences from Clostridium difficile toxin B. J Med Microbiol. 1996 Jun; 44(6):464-74.
Score: 0.007
-
Replication-defective lymphocytic choriomeningitis virus vectors expressing guinea pig cytomegalovirus gB and pp65 homologs are protective against congenital guinea pig cytomegalovirus infection. Vaccine. 2016 Apr 12; 34(17):1993-9.
Score: 0.007
-
Stability of yellow fever vaccine. Dev Biol Stand. 1996; 87:219-25.
Score: 0.007
-
Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun. 1995 Dec; 63(12):4619-27.
Score: 0.007
-
Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis. 1995 Jul; 172(1):161-72.
Score: 0.007
-
Adaptation of bluetongue virus in mosquito cells results in overexpression of NS3 proteins and release of virus particles. Arch Virol. 1995; 140(5):967-74.
Score: 0.007
-
Vector-borne emergent disease. Ann N Y Acad Sci. 1994 Dec 15; 740:126-8.
Score: 0.007
-
Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice. Antimicrob Agents Chemother. 1994 Dec; 38(12):2785-91.
Score: 0.007
-
Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A. 1994 Mar 29; 91(7):2395-400.
Score: 0.006
-
Oral administration of polymeric immunoglobulin A prevents colonization with Vibrio cholerae in neonatal mice. Infect Immun. 1994 Mar; 62(3):887-91.
Score: 0.006
-
Special symposium on mucosal immunity: protection against pathogens. Introduction. Am J Trop Med Hyg. 1994; 50(5 Suppl):1-2.
Score: 0.006
-
Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus. Infect Genet Evol. 2013 Oct; 19:292-311.
Score: 0.006
-
Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria. Am J Trop Med Hyg. 1993 Feb; 48(2):274-99.
Score: 0.006
-
Laboratory transmission of eastern equine encephalomyelitis virus to chickens by chicken mites (Acari: Dermanyssidae). J Med Entomol. 1993 Jan; 30(1):281-5.
Score: 0.006
-
Comparative infections of epizootic and enzootic strains of Venezuelan equine encephalomyelitis virus in Amblyomma cajennense (Acari: Ixodidae). J Med Entomol. 1992 Sep; 29(5):827-31.
Score: 0.006
-
Cationic liposome-DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice. Vaccine. 2012 Jan 05; 30(2):254-64.
Score: 0.005
-
Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future. Am J Trop Med Hyg. 1991 Jul; 45(1):1-43.
Score: 0.005
-
Potential for insect transmission of HIV: experimental exposure of Cimex hemipterus and Toxorhynchites amboinensis to human immunodeficiency virus. J Infect Dis. 1989 Dec; 160(6):970-7.
Score: 0.005
-
Detection of yellow fever viral RNA by nucleic acid hybridization and viral antigen by immunocytochemistry in fixed human liver. Am J Trop Med Hyg. 1989 Jun; 40(6):663-8.
Score: 0.005
-
Aedes albopictus in the United States: rapid spread of a potential disease vector. J Am Mosq Control Assoc. 1988 Sep; 4(3):356-61.
Score: 0.004
-
Executive summary of the AVMA One Health Initiative Task Force report. J Am Vet Med Assoc. 2008 Jul 15; 233(2):259-61.
Score: 0.004
-
Teaching "one medicine, one health". Am J Med. 2008 Mar; 121(3):169-70.
Score: 0.004
-
St. Louis encephalitis: lessons from the last decade. Am J Trop Med Hyg. 1987 Nov; 37(3 Suppl):40S-59S.
Score: 0.004
-
Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE). Vaccine. 2007 Sep 17; 25(37-38):6661-71.
Score: 0.004
-
Epizootic vesicular stomatitis in Colorado, 1982: some observations on the possible role of wildlife populations in an enzootic maintenance cycle. J Wildl Dis. 1987 Apr; 23(2):192-8.
Score: 0.004
-
A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus. Virology. 2007 Jun 05; 362(2):468-74.
Score: 0.004
-
Investigation of a possible yellow fever epidemic and serosurvey for flavivirus infections in northern Cameroon, 1984. Bull World Health Organ. 1987; 65(6):855-60.
Score: 0.004
-
Yellow fever: a medically neglected disease. Report on a seminar. Rev Infect Dis. 1987 Jan-Feb; 9(1):165-75.
Score: 0.004
-
Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol. 1986 Dec; 60(3):1153-5.
Score: 0.004
-
Growth characteristics of ChimeriVax-Den vaccine viruses in Aedes aegypti and Aedes albopictus from Thailand. Am J Trop Med Hyg. 2006 Nov; 75(5):986-93.
Score: 0.004
-
Aedes albopictus, an exotic mosquito vector in the United States. Ann Intern Med. 1986 Sep; 105(3):449-51.
Score: 0.004
-
Multisite monoclonal immunoassay for dengue viruses: detection of viraemic human sera and interference by heterologous antibody. J Gen Virol. 1986 Apr; 67 ( Pt 4):639-50.
Score: 0.004
-
Sensitive and specific monoclonal immunoassay for detecting yellow fever virus in laboratory and clinical specimens. J Clin Microbiol. 1986 Jan; 23(1):129-34.
Score: 0.004
-
LeDantec virus: identification as a rhabdovirus associated with human infection and formation of a new serogroup. J Gen Virol. 1985 Dec; 66 ( Pt 12):2749-54.
Score: 0.004
-
Arbovirus investigations in Argentina, 1977-1980. IV. Serologic surveys and sentinel equine program. Am J Trop Med Hyg. 1985 Sep; 34(5):966-75.
Score: 0.003
-
Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin. 2005 May-Jun; 1(3):106-11.
Score: 0.003
-
Sindbis virus isolations from Saudi Arabian mosquitoes. Trans R Soc Trop Med Hyg. 1985; 79(1):63-6.
Score: 0.003
-
Replication of chimeric yellow fever virus-dengue serotype 1-4 virus vaccine strains in dendritic and hepatic cells. Am J Trop Med Hyg. 2005 Jan; 72(1):74-81.
Score: 0.003
-
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine. 2004 Sep 09; 22(27-28):3722-6.
Score: 0.003
-
A field study on the effects of Fort Morgan virus, an arbovirus transmitted by swallow bugs, on the reproductive success of cliff swallows and symbiotic house sparrows in Morgan County, Colorado, 1976. Am J Trop Med Hyg. 1984 Sep; 33(5):981-91.
Score: 0.003
-
Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence. Am J Trop Med Hyg. 1984 Jul; 33(4):695-8.
Score: 0.003
-
Detection of yellow fever virus in serum by enzyme immunoassay. Am J Trop Med Hyg. 1984 Jan; 33(1):151-7.
Score: 0.003
-
Analysis of the replication kinetics of the ChimeriVax-DEN 1, 2, 3, 4 tetravalent virus mixture in Aedes aegypti by real-time reverse transcriptase-polymerase chain reaction. Am J Trop Med Hyg. 2004 Jan; 70(1):89-97.
Score: 0.003
-
Variation in infectivity of Saint Louis encephalitis viral strains for Culex pipiens quinquefasciatus (Diptera: Culicidae). J Med Entomol. 1983 Oct 05; 20(5):526-33.
Score: 0.003
-
Growth characteristics of the veterinary vaccine candidate ChimeriVax-West Nile (WN) virus in Aedes and Culex mosquitoes. Med Vet Entomol. 2003 Sep; 17(3):235-43.
Score: 0.003
-
Serodiagnosis of western equine encephalitis virus infections: relationships of antibody titer and test to observed onset of clinical illness. J Am Vet Med Assoc. 1983 Aug 15; 183(4):438-40.
Score: 0.003
-
Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J Infect Dis. 2003 Aug 01; 188(3):440-8.
Score: 0.003
-
Host-range restriction of chimeric yellow fever-West Nile vaccine in fish crows (Corvus ossifragus). Am J Trop Med Hyg. 2003 Jul; 69(1):78-80.
Score: 0.003
-
Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest. 1983 Apr; 48(4):399-410.
Score: 0.003
-
Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Virology. 1983 Feb; 125(1):8-17.
Score: 0.003
-
Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun. 2002 Sep; 70(9):5096-106.
Score: 0.003
-
Growth characteristics of ChimeriVax-DEN2 vaccine virus in Aedes aegypti and Aedes albopictus mosquitoes. Am J Trop Med Hyg. 2002 Sep; 67(3):260-5.
Score: 0.003
-
Fluorescent antibody techniques applied to the identification of dengue virus in infected tissue. Acta Virol. 1982 Sep; 26(5):376-81.
Score: 0.003
-
Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology. 2001 Nov 25; 290(2):309-19.
Score: 0.003
-
Diagnosis of eastern equine encephalomyelitis by immunofluorescent staining of brain tissue. Am J Vet Res. 1981 Aug; 42(8):1418-21.
Score: 0.003
-
Pathophysiologic correlations in a rhesus monkey model of yellow fever with special observations on the acute necrosis of B cell areas of lymphoid tissues. Am J Trop Med Hyg. 1981 Mar; 30(2):431-43.
Score: 0.003
-
Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic ones. FEMS Immunol Med Microbiol. 2001 Mar; 30(2):157-65.
Score: 0.003
-
Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol. 2001 Jan; 75(2):934-42.
Score: 0.003
-
Variation in virulence for mice and rhesus monkeys among St. Louis encephalitis virus strains of different origin. Am J Trop Med Hyg. 1980 Sep; 29(5):948-62.
Score: 0.002
-
Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am J Trop Med Hyg. 1980 Sep; 29(5):912-28.
Score: 0.002
-
Recovery of Tonate virus ("Bijou Bridge" strain), a member of the Venezuelan equine encephalomyelitis virus complex, from Cliff Swallow nest bugs (Oeciacus vicarius) and nestling birds in North America. Am J Trop Med Hyg. 1980 Sep; 29(5):969-83.
Score: 0.002
-
Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax-JE (YF/JE SA14--14--2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes. Am J Trop Med Hyg. 2000 Apr; 62(4):480-4.
Score: 0.002
-
Effects of humanization by variable domain resurfacing on the antiviral activity of a single-chain antibody against respiratory syncytial virus. Protein Eng. 1999 Apr; 12(4):357-62.
Score: 0.002
-
Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun. 1999 Feb; 67(2):527-38.
Score: 0.002
-
Viruses isolated from reptiles: identification of three new members of the family Rhabdoviridae. Arch Virol. 1979; 60(1):1-12.
Score: 0.002
-
Arthropod-borne encephalitides in the Americas. Bull World Health Organ. 1979; 57(4):513-33.
Score: 0.002
-
Experimental infection of house sparrows (Passer domesticus) with Rocio virus. Am J Trop Med Hyg. 1978 Nov; 27(6):1251-4.
Score: 0.002
-
Necrotizing myocarditis in mice infected with Western equine encephalitis virus: Clinical, electrocardiographic, and histopathologic correlations. J Infect Dis. 1978 Jul; 138(1):59-66.
Score: 0.002
-
Experimentally induced infection with Helicobacter pylori in squirrel monkeys (Saimiri spp.): clinical, microbiological, and histopathologic findings. Lab Anim Sci. 1998 Jun; 48(3):303-9.
Score: 0.002
-
Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine. 1997 Mar; 15(4):370-6.
Score: 0.002
-
Immunogenicity and safety of recombinant Helicobacter pylori urease in a nonhuman primate. Dig Dis Sci. 1996 Sep; 41(9):1853-62.
Score: 0.002
-
Cloning, expression and functional activities of a single chain antibody fragment directed to fusion protein of respiratory syncytial virus. Immunotechnology. 1996 Sep; 2(3):219-28.
Score: 0.002
-
Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology. 1996 Jun; 110(6):1770-5.
Score: 0.002
-
Specific amplification by PCR of rearranged genomic variable regions of immunoglobulin genes from mouse hybridoma cells. PCR Methods Appl. 1995 Apr; 4(5):256-64.
Score: 0.002
-
Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ. 1975; 52(4-6):577-92.
Score: 0.002
-
Recent isolations of Lassa virus from Nigerian rodents. Bull World Health Organ. 1975; 52(4-6):609-13.
Score: 0.002
-
Lassa virus infection in Mastomys natalensis in Sierra Leone. Gross and microscopic findings in infected and uninfected animals. Bull World Health Organ. 1975; 52(4-6):651-63.
Score: 0.002
-
Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science. 1974 Jul 19; 185(4147):263-5.
Score: 0.002
-
Lassa fever and Marburg virus disease. WHO Chron. 1974 May; 28(5):212-9.
Score: 0.002
-
Experimental studies of rhesus monkeys infected with epizootic and enzootic subtypes of Venezuelan equine encephalitis virus. J Infect Dis. 1974 Feb; 129(2):194-200.
Score: 0.002
-
Geographic distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments. J Gen Virol. 1994 Feb; 75 ( Pt 2):417-23.
Score: 0.002
-
Arbovirus studies in Nupeko forest, a possible natural focus of yellow fever virus in Nigeria. I. Description of the area and serological survey of humans and other vertebrate hosts. Trans R Soc Trop Med Hyg. 1974; 68(1):30-8.
Score: 0.002
-
Western equine encephalomyelitis: virulence markers and their epidemiologic significance. Am J Trop Med Hyg. 1993 Sep; 49(3):322-8.
Score: 0.002
-
Replication of Colorado tick fever virus within human hematopoietic progenitor cells. J Virol. 1993 Apr; 67(4):2389-95.
Score: 0.001
-
Importance of nonhuman primates in yellow fever epidemiology in Nigeria. Trop Geogr Med. 1973 Mar; 25(1):28-38.
Score: 0.001
-
Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J Nat Prod. 1992 Nov; 55(11):1569-81.
Score: 0.001
-
Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride. J Med Chem. 1992 Aug 21; 35(17):3231-8.
Score: 0.001
-
Characterization of viruses (Witwatersrand and Germiston) isolated from mosquitoes and rodents collected near Lunyo Forest, Uganda, in 1968. Arch Gesamte Virusforsch. 1972; 38(2):125-32.
Score: 0.001
-
Venezuelan equine encephalomyelitis virus infection in and transmission by the tick Amblyomma cajennense (Arachnida: Ixodidae). J Med Entomol. 1991 May; 28(3):405-9.
Score: 0.001
-
Effects of thorotrast on humoral antibody, viral multiplication, and interferon during infection with St. Louis encephalitis virus in mice. J Infect Dis. 1971 Mar; 123(3):297-300.
Score: 0.001
-
Localized eastern equine encephalitis in Santiago del Estero Province, Argentina, without human infection. Medicina (B Aires). 1991; 51(1):3-8.
Score: 0.001
-
Labile serum factor and its effect on arbovirus neutralization. Appl Microbiol. 1971 Jan; 21(1):79-83.
Score: 0.001
-
Comparison of methods for removal of nonspecific inhibitors of arbovirus hemagglutination. Appl Microbiol. 1970 Nov; 20(5):748-53.
Score: 0.001
-
Attenuation of wild-type yellow fever virus by passage in HeLa cells. J Gen Virol. 1990 Oct; 71 ( Pt 10):2301-6.
Score: 0.001
-
Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol. 1989 Dec; 40(4):396-9.
Score: 0.001
-
Genetic variation and microevolution of dengue 2 virus in Southeast Asia. Virology. 1989 Oct; 172(2):523-35.
Score: 0.001
-
Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg. 1989 May-Jun; 83(3):401-6.
Score: 0.001
-
Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J Gen Virol. 1988 Aug; 69 ( Pt 8):1921-9.
Score: 0.001
-
Human infections with Tensaw virus in south Florida: evidence that Tensaw virus subtypes stimulate the production of antibodies reactive with closely related Bunyamwera serogroup viruses. Am J Trop Med Hyg. 1988 Jul; 39(1):117-22.
Score: 0.001
-
Effect of human gamma interferon on yellow fever virus infection. Am J Trop Med Hyg. 1988 May; 38(3):647-50.
Score: 0.001
-
Epidemic yellow fever in eastern Nigeria, 1986. Lancet. 1988 Mar 19; 1(8586):630-3.
Score: 0.001
-
Host-feeding patterns of Argentine mosquitoes (Diptera: Culicidae) collected during and after an epizootic of western equine encephalitis. J Med Entomol. 1987 Mar; 24(2):260-7.
Score: 0.001
-
Arbovirus isolations from mosquitoes collected during and after the 1982-1983 epizootic of western equine encephalitis in Argentina. Am J Trop Med Hyg. 1987 Jan; 36(1):107-13.
Score: 0.001
-
A newly recognized vesiculovirus, Calchaqui virus, and subtypes of Melao and Maguari viruses from Argentina, with serologic evidence for infections of humans and horses. Am J Trop Med Hyg. 1987 Jan; 36(1):114-9.
Score: 0.001
-
Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups. Am J Trop Med Hyg. 1987 Jan; 36(1):177-82.
Score: 0.001
-
Epizootic vesicular stomatitis in Colorado, 1982: epidemiologic studies along the northern Colorado front range. Am J Trop Med Hyg. 1987 Jan; 36(1):183-8.
Score: 0.001
-
Genetic heterogeneity of yellow fever virus strains from Africa and the Americas. J Gen Virol. 1986 Jan; 67 ( Pt 1):209-13.
Score: 0.001
-
Investigations of the vertebrate hosts of eastern equine encephalitis during an epizootic in Michigan, 1980. Am J Trop Med Hyg. 1985 Nov; 34(6):1190-202.
Score: 0.001
-
Arbovirus investigations in Argentina, 1977-1980. II. Arthropod collections and virus isolations from Argentine mosquitoes. Am J Trop Med Hyg. 1985 Sep; 34(5):945-55.
Score: 0.001
-
Arbovirus investigations in Argentina, 1977-1980. III. Identification and characterization of viruses isolated, including new subtypes of western and Venezuelan equine encephalitis viruses and four new bunyaviruses (Las Maloyas, Resistencia, Barranqueras, and Antequera). Am J Trop Med Hyg. 1985 Sep; 34(5):956-65.
Score: 0.001
-
Arbovirus investigations in Argentina, 1977-1980. I. Historical aspects and description of study sites. Am J Trop Med Hyg. 1985 Sep; 34(5):937-44.
Score: 0.001
-
Isolation of St. Louis encephalitis virus from adult Dermacentor variabilis (Acari: Ixodidae). J Med Entomol. 1985 Mar 22; 22(2):232-3.
Score: 0.001
-
The use of an animal-baited net trap for collecting mosquitoes during western equine encephalitis investigations in Argentina. J Am Mosq Control Assoc. 1985 Mar; 1(1):43-7.
Score: 0.001
-
Identification of a new Venezuelan equine encephalitis virus from Brazil. Am J Trop Med Hyg. 1982 Nov; 31(6):1260-72.
Score: 0.001
-
Arbovirus subtyping: applications to epidemiologic studies, availability of reagents, and testing services. Am J Epidemiol. 1981 Nov; 114(5):619-31.
Score: 0.001
-
Arbovirus infections among laboratory personnel in Ibadan, Nigeria. Am J Trop Med Hyg. 1981 Jul; 30(4):855-61.
Score: 0.001
-
Experimental transmission of Rocio virus by mosquitoes. Am J Trop Med Hyg. 1981 Mar; 30(2):465-72.
Score: 0.001
-
Viruses isolated from Aedeomyia squamipennis mosquitoes collected in Panama, Ecuador, and Argentina: establishment of the Gamboa serogroup. Am J Trop Med Hyg. 1981 Jan; 30(1):219-23.
Score: 0.001
-
[Sylvatic yellow fever in Africa recent advances and present approach (author's transl)]. Med Trop (Mars). 1981 Jan-Feb; 41(1):31-43.
Score: 0.001
-
[Yellow fever in Senegal from 1976 to 1980 (author's transl)]. Med Trop (Mars). 1981 Jan-Feb; 41(1):45-51.
Score: 0.001
-
Geographic variation among St. Louis encephalitis virus strains in the viremic responses of avian hosts. Am J Trop Med Hyg. 1980 Nov; 29(6):1411-9.
Score: 0.001
-
Characterization of Fort Morgan virus, an alphavirus of the western equine encephalitis virus complex in an unusual ecosystem. Am J Trop Med Hyg. 1980 Nov; 29(6):1428-40.
Score: 0.001
-
Yellow fever in the Gambia, 1978--1979: entomological aspects and epidemiological correlations. Am J Trop Med Hyg. 1980 Sep; 29(5):929-40.
Score: 0.001
-
Transmission of St. Louis encephalitis virus from Argentina by mosquitoes of the Culex pipiens (Diptera: Culicidae) complex. J Med Entomol. 1980 May 31; 17(3):282-5.
Score: 0.001
-
Variation among strains of St. Louis encephalitis virus: basis for a genetic, pathogenetic, and epidemiologic classification. Ann N Y Acad Sci. 1980; 354:219-37.
Score: 0.001
-
Tataguine virus infection in mice and hamsters. Microbios. 1980; 27(108):89-96.
Score: 0.001
-
Studies of glucose metabolism in rhesus monkeys after Venezuelan equine encephalitis virus infection. J Med Virol. 1980; 6(3):227-34.
Score: 0.001
-
St. Louis encephalitis virus transmission following multiple feeding of Culex pipiens pipiens (Diptera: Culicidae) during a single gonotrophic cycle. J Med Entomol. 1979 Oct 12; 16(3):254-8.
Score: 0.001
-
Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans R Soc Trop Med Hyg. 1977; 71(1):60-5.
Score: 0.000
-
Arbovirus studies in Nupeko forest, a possible natural focus of yellow fever virus in Nigeria. II. Entomological investigations and viruses isolated. Trans R Soc Trop Med Hyg. 1974; 68(1):39-43.
Score: 0.000
-
Bwamba virus infection: a sero-survey of veterbrates in five ecological zones in Nigeria. Trans R Soc Trop Med Hyg. 1974; 68(6):461-5.
Score: 0.000
-
Studies on Tataguine infection in Nigeria. Trop Geogr Med. 1972 Sep; 24(3):298-302.
Score: 0.000